Assessment of Injectable Medication Platforms

Clinical trial NCT05367531 · UNKNOWN

Trial details

NCT number: NCT05367531
Sponsor: Canadian Forces Health Services Centre Ottawa
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Overdose Antidote Bleeding Allergic Reaction

Start date: 2022-04-30
Primary completion: 2024-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.